Common Genetic Variation in CYP17A1 and Response to Abiraterone Acetate in Patients with Metastatic Castration-Resistant Prostate Cancer.
about
TSPYL Family Regulates CYP17A1 and CYP3A4 Expression: Potential Mechanism Contributing to Abiraterone Response in Metastatic Castration-Resistant Prostate Cancer.Combined abiraterone acetate plus prednisone, salvage prostate bed radiotherapy and LH-RH agonists (CARLHA-GEP12) in biochemically-relapsing prostate cancer patients following prostatectomy: A phase I study of the GETUG/GEP.
P2860
Common Genetic Variation in CYP17A1 and Response to Abiraterone Acetate in Patients with Metastatic Castration-Resistant Prostate Cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Common Genetic Variation in CY ...... ion-Resistant Prostate Cancer.
@en
Common Genetic Variation in CY ...... ion-Resistant Prostate Cancer.
@nl
type
label
Common Genetic Variation in CY ...... ion-Resistant Prostate Cancer.
@en
Common Genetic Variation in CY ...... ion-Resistant Prostate Cancer.
@nl
prefLabel
Common Genetic Variation in CY ...... ion-Resistant Prostate Cancer.
@en
Common Genetic Variation in CY ...... ion-Resistant Prostate Cancer.
@nl
P2093
P2860
P356
P1476
Common Genetic Variation in CY ...... ion-Resistant Prostate Cancer.
@en
P2093
Ben Y Zhang
David W Hillman
Manish Kohli
Rhea Kohli
Tanvi Kohli
P2860
P356
10.3390/IJMS17071097
P407
P577
2016-07-09T00:00:00Z